Descriptive analysis of the national drug adverse events (AEs) database in Lebanon
Our results showed that Lebanon, a country that suffers from a turbulent economic and health context, was able to implement a PV system and operate with efficiency while evaluating a 5-year worth of ICSR reports. The dissemination of this information promotes stakeholder awareness by encouraging a collaborative approach among patients, healthcare providers, and regulatory authorities in Lebanon. However, further research is warranted to investigate factors contributing to MEs in Lebanon.
Authors
- Abeer Zeitoun (ORCID: https://orcid.org/0000-0002-2720-413X)
- Joya-Maria Karam
- Souheil R. Hallit (ORCID: https://orcid.org/0000-0001-6918-5689)
- Rita Karam (ORCID: https://orcid.org/0000-0002-1977-2778)
- Aya Ibrahim (ORCID: https://orcid.org/0000-0003-1408-7322)
- Sarah Reda El Sayed (ORCID: https://orcid.org/0000-0002-6556-8583)
Institutions
- Effat University (SA)
- Applied Science Private University (JO)
- Lebanese University (LB)
- Holy Spirit University of Kaslik (LB)
- Ministry of Public Health (LB)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1080/20523211.2025.2473014
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00